Methotrexate preserves anti-PD1 anti-tumor benefits while reducing arthritic inflammation in a tumor and ICI-arthritis combination mouse model

被引：0
|
作者：
Papadopoulos, Theodore
Santinon, Francois
Naranjo, Carolina Lopez
Hudson, Marie
Del Rincon, Sonia Victoria
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2025年 / 13卷 / 02期
关键词：
D O I：
10.1158/2326-6074.IO2025-A089
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A089
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Remarkable anti-tumor response in a HCC transgenic mouse model treated with GNS561 in combination with anti-PD1
    Rachid, Madani
    Tijeras-Raballand, Annemilai
    Serdjebi, Cindy
    Brun, Sonia
    Ansaldi, Christelle
    Raymond, Eric
    Halfon, Philippe
    CANCER RESEARCH, 2020, 80 (16)
  • [2] Caffeine-enhanced anti-tumor activity of anti-PD1 monoclonal antibody
    Tej, Gullanki Naga Venkata Charan
    Neogi, Kaushik
    Nayak, Prasanta Kumar
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 77
  • [3] Cabozantinib in combination with anti-PD1 immune checkpoint inhibitor in syngeneic tumor mouse models
    Rolland, S.
    Klinz, S. G.
    Meyer-Losic, F.
    Nahkle, J.
    Delille, R.
    de Boisferon, M. Hillairet
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Fungal Depletion Bolsters Anti-Tumor Immune Response Elicited by Anti-PD1 Alone and in Combination with Radiation Therapy
    Stevens, S.
    Jang, J. K.
    Kershaw, K.
    Viramontes, J.
    Dar, T. B.
    Nguyen, A. T.
    Henson, R.
    Guarnerio, J.
    Underhill, D.
    Shiao, S. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S166 - S166
  • [5] Anti-GITR with Radiation Therapy Enhances Anti-Tumor Abscopal Effects in Anti-PD1 Resistant Murine Model
    Cushman, T. R.
    Schoenhals, J.
    Barsoumian, H.
    Caetano, M. D. S.
    Cadena, A.
    Younes, A.
    Li, A.
    Niknam, S.
    Cortez, M. A.
    Welsh, J. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S153 - S153
  • [6] AAV Mediated Expression of Mouse IL-12 Shows Potent Anti-Tumor Activity and Immune Response Alone and in Combination with Anti-PD1 in Syngeneic Murine Tumor Models
    Sutton, David
    Prentiss, Pilar
    Furmanski, Brian
    MOLECULAR THERAPY, 2022, 30 (04) : 161 - 161
  • [7] OMX IS A TUMOR MICROENVIRONMENT MODIFIER THAT RESTORES ANTI-TUMOR IMMUNITY AND IMPROVES ANTI-TUMOR EFFICACY BY REDUCING TUMOR HYPOXIA IN INTRACRANIAL GLIOBLASTOMA MOUSE MODEL
    Le Moan, Natacha
    Davis, Tina
    Leung, Philberta
    Ng, Sarah
    Winger, Jonathan
    Cary, Stephen
    Butowski, Nicholas
    Krtolica, Ana
    NEURO-ONCOLOGY, 2018, 20 : 259 - 259
  • [8] Synergistic anti-tumor activity with a combination of anti-PD1 antibody and the cyclophilin inhibitor, rencofilstat, in the Hep53.4 fatty liver model of hepatocellular carcinoma
    Ure, Daren
    Leslie, Jack
    Variya, Bhavesh
    Foster, Robert
    Mann, Jelena
    Mann, Derek A.
    JOURNAL OF HEPATOLOGY, 2022, 77 : S660 - S660
  • [9] Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment
    Lang, Julie
    Capasso, Anna
    Jordan, Kimberly R.
    French, Jena D.
    Kar, Adwitiya
    Bagby, Stacey M.
    Barbee, Jacob
    Yacob, Betelehem W.
    Head, Lia S.
    Tompkins, Kenneth D.
    Freed, Brian M.
    Somerset, Hilary
    Clark, Toshimasa J.
    Pitts, Todd M.
    Messersmith, Wells A.
    Eckhardt, S. Gail
    Wierman, Margaret E.
    Leong, Stephen
    Kiseljak-Vassiliades, Katja
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (01): : 26 - 42
  • [10] DSP-0692, a selective SCD inhibitor, enhances the anti-tumor activity of anti-PD1 antibody
    Sugaru, Eiji
    Furuta, Yudai
    Nagagaki, Yoshikazu
    Ikeda, Satoshi
    Fukunaga, Yuichi
    Urnehara, Hiroki
    Otsubo, Tsuguteru
    Watanabe, Manabu
    Tojo, Shingo
    Hashizume, Miki
    Matsuki, Yasushi
    Ban, Hitoshi
    CANCER RESEARCH, 2019, 79 (13)
12345